Your browser is out-of-date!

Update your browser to view this website correctly.

To continue, please select your country of domicile and investor type. Depending on your domicile and the investor type that you select, you will have full or restricted access to the information due to legal reasons.

Retail clients: according to Art. 4 Abs. 2 FinSA

Professional/Institutional investors: according to Art. 4 paragraph 3-5 and Art. 5 paragraph 1 and 3-4 FinSA and Art. 10 paragraph 3 and 3ter CISA in conjunction with Art. 6a CISO



By using the website, you confirm that you have read, understood and accepted the general information provided by the Bellevue Group AG as well as these legal provisions. These may be subject to change and the use of the site may be restricted or terminated at any time without prior notice.

The information, products, data, services, tools and documents contained or described on this site ("website content") are for information purposes only and constitute neither an advertisement or recommendation nor an offer or solicitation (to buy) or redemption (sell) investment instruments, to effect any transaction or to enter into any legal relations.

The financial products mentioned on this site are not suitable for all investors. The information contained on this site does not constitute a financial, legal, fiscal or any other recommendation. Investment or other decisions should not be made solely on the basis of this document. In particular, you should not enter into any investment before you have read the corresponding fund agreement or legal prospectus, the annual and semi-annual reports, the articles of association (as far as they are applicable), as well as all other documents, as required in accordance with local legislation or the regulations applied in the legal jurisdictions or countries in which the corresponding investment fund has been licensed or approved for public offer or sale to the public.

In order to determine whether the investment in shares of a certain investment fund meets your specific requirements and matches your envisaged risks, we recommend that you contact an independent financial adviser. Furthermore, we recommend that you consult an independent tax adviser in order to obtain information on the tax regulations relating to a specific investment in your legal jurisdiction and with regard to your personal circumstances. In particular tax treatment depends on individual circumstances and may be subject to change.


Past performance is not an indication or guarantee of the future performance of the investment. The value of investments may be subject to fluctuations and, under certain circumstances, investors may not get back the full amount invested. Changes in foreign-exchange rates may also cause the value of investments to go up or down.

For a full explanation of risks and the overall risk profile of financial products mentioned on this site, please refer to the relevant Key Investor Information Documents (KIDs) and Prospectuses.


By accessing this website you state that you agree with the data protection statement. If you do not agree with this statement you should refrain from accessing any further pages of this website. This statement may be updated at any time. We therefore recommend that you check this statement regularly.


By clicking on "Accept", you confirm that you agree to the legal provisions. Alternatively, you can select "I don't accept" if you wish to leave the website

Healthcare - 
a growth sector

The global market for healthcare products and services is estimated to be worth over $7.5 trillion and will remain an area of sustained structural demand and growth for many decades to come, for multiple key reasons.

An ageing population in developed markets

There is a longstanding relationship between age and healthcare expenditure. The elderly spend disproportionately more on healthcare compared to younger age groups, with the majority of expenditure per capita from the over 60s.

open glightbox

Increasing wealth in middle income and developing countries

Over the past 20 years we have seen a significant reduction in the proportion of the global population living in absolute poverty and a rapid increase in the proportion of the world’s middle class. According to the OECD, the global middle class will expand from 1.8 billion people in 2009 to 3.2 billion by 2020 and 4.9 billion by 2030.

Healthcare systems in transition economies have been experiencing rapid growth. Governments in these countries are establishing and expanding their healthcare systems on the one hand while a growing middle class is increasing its consumption of private healthcare services on the other.

Greater understanding of the pathogenesis of disease

New technologies helping the identification of gene patterns and protein expression are allowing scientists to define disease states at the molecular level and appreciate the variation in pathology between individuals. This is driving the development of new, more targeted interventions and thus allowing physicians to tailor treatments to individual needs.

Cost containment and healthcare reform

Inevitably, there comes a point where a society feels that the cost of healthcare is too much, which is arguably the case in a number of developed countries. Bellevue does not expect to see significant increases in the proportion of GDP per capita available for healthcare in these developed markets.

Reforming healthcare delivery to improve outcomes and deliver better value for money is a constant theme in developed economies. It is a politicised debate in the United States, which is the largest single market (at US$2.9 trillion per annum) for healthcare products and services. While pricing convergence seems inevitable in the long-term, especially for drugs, this will be a slow trend as there will not be a graduated shift towards a government delivered single provider system in the US, as is common in most European countries. Many of the most important, rapidly developing markets (e.g. India and China) remain dependent on private providers to deliver services.

10 Key themes that drive our thinking